Nomura Remains Buyers of Allergen (AGN) Into Deal Close
Tweet Send to a Friend
Nomura Securities analyst Shibani Malhotra reiterated a Buy rating and $350 price target on Allergen (NYSE: AGN), saying they remain ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


